Welcome to Multibagg AI
Log in to access personalized features
Portfolio
Alerts
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Discovery themes featuring this stock
Denis Chem Lab Ltd is a pharmaceutical company primarily focused on manufacturing sterile intravenous (IV) injectables and transfusion solutions.
The company leverages advanced Blow Fill Seal (BFS) technology to produce IV fluids in plastic bottles, reaching a capacity of 15 million units per annum by 2016.
In 2021, Denis Chem Lab expanded its production capacity for 100 ml Eurohead 'Aquapulse' products, adding 12,00,000 bottles per month.
The company operates a state-of-the-art manufacturing facility that adheres to WHO's GMP specifications, ensuring high-quality pharmaceutical products.
Denis Chem Lab's product portfolio includes antibiotic injections, diuretic injections, and plasma volume expanders, highlighting a wide range of specialized medical solutions.
Pharmaceuticals & Biotechnology
Pharmaceuticals
99 Cr
Low Risk
12.4
37.7
13.7
1.1
100.50
56.10
Sales CAGR
Profit CAGR
ROE
ROCE
Denis Chem Lab Ltd (DENISCHEM) is currently trading at 71.15 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Denis Chem Lab Ltd is a pharmaceutical company primarily focused on manufacturing sterile intravenous (IV) injectables and transfusion solutions. The company leverages advanced Blow Fill Seal (BFS) technology to produce IV fluids in plastic bottles, reaching a capacity of 15 million units per annum by 2016. In 2021, Denis Chem Lab expanded its production capacity for 100 ml Eurohead 'Aquapulse' products, adding 12,00,000 bottles per month. The company operates a state-of-the-art manufacturing facility that adheres to WHO's GMP specifications, ensuring high-quality pharmaceutical products. Denis Chem Lab's product portfolio includes antibiotic injections, diuretic injections, and plasma volume expanders, highlighting a wide range of specialized medical solutions.
Over the past 52 weeks, Denis Chem Lab Ltd has traded between a low of ₹56.10 and a high of ₹100.50. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Denis Chem Lab Ltd has a market capitalization of approximately 98.98. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Denis Chem Lab Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 12.40 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 98.98 Cr, Denis Chem Lab Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Denis Chem Lab Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Denis Chem Lab Ltd is 12.40. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Bearish
1
Neutral
7
Bullish
6
Bearish
21
Neutral
8
Bullish
17
Bearish
20
Neutral
1
Bullish
11
Bearish
1
Neutral
7
Bullish
6
Bearish
1
Neutral
7
Bullish
6
Bearish
20
Neutral
1
Bullish
11
Bearish
20
Neutral
1
Bullish
11
Bearish
20
Neutral
1
Bullish
11
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
30.21 | 106 Cr | -24.21 | 2.23 | 0.00 | -29.76 | -20.97 | -5.07 | ||
78.20 | 105 Cr | 51.38 | 2.17 | 0.00 | 2.17 | 5.12 | 2.74 | ||
90.05 | 100 Cr | 25.19 | 1.69 | 0.22 | 9.79 | 13.29 | 4.71 | ||
49.89 | 99 Cr | 65.03 | 4.34 | 0.00 | 2.96 | 6.55 | 3.46 | ||
71.15 | 99 Cr | 12.40 | 1.08 | 3.51 | 9.18 | 13.14 | 6.39 | ||
133.75 | 92 Cr | -77.32 | 20.03 | 0.00 | 67.65 | -85.76 | -4.24 | ||
57.85 | 91 Cr | 47.21 | 3.21 | 0.00 | 6.80 | 10.18 | 5.52 | ||
| Median: 7 Co. | — | 71.15 | 99 Cr | 25.19 | 2.23 | 0.00 | 6.80 | 6.55 | 3.46 |
